Multi-institutional analysis of renal function outcomes following radical nephroureterectomy and partial ureterectomy for upper tract urothelial carcinoma

Urologic Oncology: Seminars and Original Investigations

Volumn 33, Issue 6, 2015, Pages 268.e1-268.e7

  Singla, Nirmish ^a   Gayed, Bishoy A ^a   Bagrodia, Aditya ^a   Krabbe, Laura Maria ^a   Palazzi, Kerrin L ^b   Mirheydar, Hossein ^b   Harrow, Brian ^a   Jacobs, Corbin ^a   Youssef, Ramy ^a   Darwish, Oussama ^a   Sagalowsky, Arthur ^a   Lotan, Yair ^a   Derweesh, Ithaar ^b   Margulis, Vitaly ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Rady Children's Specialists of San Diego   (United States)

Author keywords

Partial ureterectomy; Radical nephroureterectomy; Renal function; Upper tract urothelial carcinoma

Indexed keywords

CREATININE;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; EVENT FREE SURVIVAL; FEMALE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; OUTCOME ASSESSMENT; PARTIAL URETERECTOMY; PRIORITY JOURNAL; RADICAL NEPHROURETERECTOMY; TRANSITIONAL CELL CARCINOMA; CLINICAL TRIAL; COHORT ANALYSIS; KIDNEY; KIDNEY FUNCTION TEST; MIDDLE AGED; MULTICENTER STUDY; NEPHRECTOMY; PATHOLOGY; PROCEDURES; TREATMENT OUTCOME; URETER; URETERAL NEOPLASMS; UROLOGIC NEOPLASMS;

AGED; COHORT STUDIES; FEMALE; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NEPHRECTOMY; TREATMENT OUTCOME; URETER; URETERAL NEOPLASMS; UROLOGIC NEOPLASMS;

EID: 84929959809     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2015.03.006     Document Type: Article

References (26)

1. Munoz J.J., Ellison L.M. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 2000, 164:1523-1525.
2. Gupta R., Paner G.P., Amin M.B. Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting. Adv Anat Pathol 2008, 15:127-139.
3. Margulis V., Shariat S.F., Matin S.F., et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 2009, 115:1224-1233.
4. Lughezzani G., Sun M., Perrotte P., et al. Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study. Eur Urol 2010, 57:956-962.
5. Phe V., Cussenot O., Bitker M.O., et al. Does the surgical technique for management of the distal ureter influence the outcome after nephroureterectomy?. BJU Int 2011, 108:130-138.
6. Zigeuner R., Pummer K. Urothelial carcinoma of the upper urinary tract: surgical approach and prognostic factors. Eur Urol 2008, 53:720-731.
7. Malcolm J.B., Bagrodia A., Derweesh I.H., et al. Comparison of rates and risk factors for developing chronic renal insufficiency, proteinuria and metabolic acidosis after radical or partial nephrectomy. BJU Int 2009, 104:476-481.
8. Huang W.C., Levey A.S., Serio A.M., et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 2006, 7:735-740.
9. Lucas S.M., Stern J.M., Adibi M., et al. Renal function outcomes in patients treated for renal masses smaller than 4cm by ablative and extirpative techniques. J Urol 2008, 179:75-79.
10. Raman J.D., Lin Y.K., Kaag M., et al. High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy. Urol Oncol 2014, 32:e9-e14.
11. Silberstein J.L., Power N.E., Savage C., et al. Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma. J Urol 2012, 187:429-434.
12. Xylinas E., Rink M., Margulis V., et al. Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephron-ureterectomy. BJU Int 2013, 112:453-461.
13. Kaag M.G., O'Malley R.L., O'Malley P., et al. Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Eur Urol 2010, 58:581-587.
14. Dash A., Galsky M.D., Vickers A.J., et al. Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder. Cancer 2006, 107:506-513.
15. Jeldres C., Lughezzani G., Sun M., et al. Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter. J Urol 2010, 183:1324-1329.
16. Lughezzani G., Jeldres C., Isbarn H., et al. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients. Eur J Cancer 2009, 45:3291-3297.
17. Colin P., Ouzzane A., Pignot G., et al. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicenter study. BJU Int 2012, 110:1134-1141.
18. Bagrodia A., Kuehhas F.E., Gayed B.A., et al. Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomyin upper tract urothelial carcinoma. Urology 2013, 81:972-977.
19. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999, 130:461-470.
20. American Joint Committee on Cancer (AJCC) Cancer Staging Manual 2010, Springer, New York, NY. 7th ed.
21. Epstein J.I., Amin M.B., Reuter V.R., et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998, 22:1435-1448.
22. Tavora F., Fajardo D.A., Lee T.K., et al. Small endoscopic biopsies of the ureter and renal pelvis: pathologic pitfalls. Am J Surg Pathol 2009, 33:1540-1546.
23. Scolieri M.J., Paik M.L., Brown S.L., et al. Limitations of computed tomography in the preoperative staging of upper tract urothelial carcinoma. Urology 2000, 56:930-934.
24. Hall M.C., Womack S., Sagalowsky A.I., et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 1998, 52:594-601.
25. Hussain S.A., Stocken D.D., Riley P., et al. A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer. Br J Cancer 2004, 91:844-849.
26. Castro A.F., Coresh J. CKD surveillance using laboratory data from the population-based National Health and Nutrition Examination Survey (NHANES). Am J Kidney Dis 2009, 53:46-55.